Gate Bioscience has raised $60 million to develop a new type of pill-based medicine — which it calls a molecular gate — that can go after the spectrum of malicious proteins.
Pat Sharp The Brisbane, CA biotech was started in 2021 by Jordi Mata‐Fink, a…
Click here to view original post
